XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash stock-based compensation expenses of $338 and $397, respectively) 1,102 1,552
General and administrative expenses (including non-cash stock-based compensation expenses of $458 and $658, respectively) 1,614 1,834
Total operating costs and expenses 2,716 3,386
Loss from operations (2,716) (3,386)
Interest income 131 173
Net loss (2,585) (3,213)
Less: Net loss attributable to noncontrolling interest (20) (29)
Net loss attributable to common shareholders $ (2,565) $ (3,184)
Net loss per common share attributable to common shareholders:    
Basic $ (0.08) $ (0.10)
Diluted $ (0.08) $ (0.10)
Weighted average common shares outstanding:    
Basic 33,240 32,197
Diluted 33,240 32,197